期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Narciclasine,a novel topoisomerase I inhibitor,exhibited potent anti-cancer activity against cancer cells
1
作者 Meichen Wang Leilei Liang +9 位作者 Rong Wang shutao jia Chang Xu Yuting Wang Min Luo Qiqi Lin Min Yang Hongyu Zhou Dandan Liu Chen Qing 《Natural Products and Bioprospecting》 2023年第1期482-492,共11页
DNA topoisomerases are essential nuclear enzymes in correcting topological DNA errors and maintaining DNA integrity.Topoisomerase inhibitors are a significant class of cancer chemotherapeutics with a definite curative... DNA topoisomerases are essential nuclear enzymes in correcting topological DNA errors and maintaining DNA integrity.Topoisomerase inhibitors are a significant class of cancer chemotherapeutics with a definite curative effect.Natural products are a rich source of lead compounds for drug discovery,including anti-tumor drugs.In this study,we found that narciclasine(NCS),an amaryllidaceae alkaloid,is a novel inhibitor of topoisomerase I(topo I).Our data demonstrated that NCS inhibited topo I activity and reversed its unwinding effect on p-HOT DNA substrate.However,it had no obvious effect on topo II activity.The molecular mechanism of NCS inhibited topo I showed that NCS did not stabilize topo-DNA covalent complexes in cells,indicating that NCS is not a topo I poison.A blind docking result showed that NCS could bind to topo I,suggesting that NCS might be a topo I suppressor.Additionally,NCS exhibited a potent anti-proliferation effect in various cancer cells.NCS arrested the cell cycle at G_(2)/M phase and induced cell apoptosis.Our study reveals the antitumor mechanisms of NCS and provides a good foundation for the development of anti-cancer drugs based on topo I inhibition. 展开更多
关键词 Topoisomerase Narciclasine(NCS) Topo I-DNA covalent complex DNA damage Cell cycle Apoptosis
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部